The 90-day prognostic value of copeptin in acute intracerebral hemorrhage

Neurological Sciences

Volumn 35, Issue 11, 2014, Pages 1673-1679

  Wei, Zhi Jun ^a   Ou, Yang Qi ^a   Li, Xue ^a   Li, Hua ^a  

^a Beijing Military Region General Hospital   (China)

Author keywords

Acute intracerebral hemorrhage; Copeptin; Prognostic

Indexed keywords

COPEPTIN; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HEMPHILL INTRACEREBRAL HEMORRHAGE SCORE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; BLOOD; CONVALESCENCE; MIDDLE AGED; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPEPTIDES; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PROGNOSIS; RECOVERY OF FUNCTION; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84919932131     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1809-2     Document Type: Article

References (32)

1. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP (2009) Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 40:2068–2072
2. Alvarez-Sabin J, Delgado P, Abilleira S, Molina CA, Arenillas J et al (2004) Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35:1316–1322
3. Delgado P, Alvarez Sabin J, Montaner J (2007) Biological markers in spontaneous intracerebral hemorrhage. Neurologia (Barcelona, Spain) 22:448–455
4. Nickel CH, Bingisser R, Morgenthaler NG (2012) The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 10:7
5. Barat C, Simpson L, Breslow E (2004) Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus. Biochemistry 43:8191–8203
6. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28:219–226
7. Stoiser B, Mörtl D, Hülsmann M, Berger R, Struck J, Morgenthaler NG et al (2006) Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 36:771–778
8. Voors AA, von Haehling S, Anker SD, Hillege HL, Struck J, Hartmann O et al (2009) C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 30:1187–1194
9. De Marchis GM, Katan M, Weck A et al (2013) Copeptin adds prognostic information after ischemic stroke results from the CoRisk study. Neurology 80:1278–1286
10. Dong X, Tao DB, Wang YX et al (2013) Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study. Neurol Sci 34:1591–1595
11. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A et al (2010) Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 10:34
12. Dong XQ, Huang M, Yu WH et al (2011) Change in plasma copeptin level after acute spontaneous basal ganglia hemorrhage. Peptides 32:253–257
13. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M et al (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–1305
14. Goldstein LB, Samsa GP, Matchar DB, Horner RD (2004) Charlson index comorbidity adjustment for ischemic stroke outcome studies. Stroke 35:1941–1945
15. Gill MR, Reiley DG, Green SM (2004) Interrater reliability of Glasgow Coma Scale scores in the emergency department. Ann Emerg Med 43:215–223
16. Bonita RBR (1988) Modification of rankin scale: recovery of motor function after stroke. Stroke 19:1497–1500
17. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112–119
18. Zhang JL, Yin CH, Zhang Y et al (2013) Plasma copeptin and long-term outcomes in acute ischemic stroke. Acta Neurol Scand 128:372–380
19. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B (2009) Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 94:123–129
20. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Muller K, Meckel S, Gass A, Kappos L et al (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66:799–808
21. Zhang A, Li J, Li X et al (2013) The prognostic value of copeptin for acute intracerebral hemorrhage patients. Exp Ther Med 5:467–470
22. Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos LB, Steck AB, Engelter SB, Müller BF, Christ-Crain M, Katan M (2010) Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 41:1564–1567
23. Zhu XD, Chen JS, Zhou F et al (2011) Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care 15:R288
24. Delgado P, Alvarez-Sabin J, Abilleira S, Santamarina E, Purroy F, Arenillas JF, Molina CA, Fernandez-Cadenas I, Rosell A, Montaner J (2006) Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology 67:94–98
25. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS (2002) Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58:624–629
26. Delgado P, Alvarez Sabin J, Santamarina E, Molina CA, Quintana M, Rosell A, Montaner J (2006) Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke 37:2837–2839
27. Gebel JM Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP (2002) Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33:2636–2641
28. Molnar AH, Varga C, Berko A, Rojik I, Parducz A, Laszlo F, Laszlo FA (2008) Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia. Acta Neurochir (Wien) 150:265–271
29. Delgado TJ, Arbab MAR, Warberg J, Svendgaard NA (1988) The role of vasopressin in acute cerebral vasospasm. J Neurosurg 68:266–273
30. Shuaib A, Wang CX, Yang T, Noor R (2002) Effects of nonpeptide V1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 33:3033–3037
31. Kozniewska E, Gadamski R, Klapczynska K, Wojda R, Rafalowska J (2008) Morphological changes in the brain during experimental hyponatremia. Do vasopressin and gender matter? Folia Neuropath 46:165–170
32. Kozniewska E, Romaniuk K (2008) Vasopressin in vascular regulation and water homeostasis in the brain. J Physiol Pharmacol 59(Suppl 8):109–116